Literature DB >> 27688080

Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors.

Cristina Díaz Del Arco1, J Ángel Díaz Pérez2, Luis Ortega Medina3, Javier Sastre Valera4, M Jesús Fernández Aceñero3.   

Abstract

Neuroendocrine pancreatic tumors (PanNETs) are graded on the basis of their proliferative activity. Cytological samples are commonly the only samples available, but the determination of Ki-67 in cytology and its reliability as a measure of tumor mitotic activity is not well settled. We have retrospectively reviewed all the cases of FNA under EUS control of PanNETs in a 10-year period (2006-2016) in the Hospital Clínico San Carlos (Madrid). We identified 10 PanNET cases with histological correlation. Median age was 49.4 years and the patients were mainly women. PanNETs were located more frequently in the tail of the pancreas, with a median size of 33.8 mm. None of our cases was a grade 3 tumor. The seven grade 1 tumors confirmed in histology had consistent Ki-67 in cytology. In three cases (30 %), there were discrepancies between the Ki-67 index measured in cytology and histology, and the differences ranged from 2 to 15 %; all these cases were grade 2 tumors in histology and were graded as grade 1 tumors in FNA material. Our results are consistent with previous studies which showed understaging when tumor grade was assessed in cytological samples, mainly in G2 tumors. Previous literature has shown that Ki-67 assessment in EUS-FNA samples is a useful tool to rule out G3 tumors, but can be problematic for distinguishing G1 and G2 tumors.

Entities:  

Keywords:  Cytology; Fine-needle aspiration; Grading; Ki-67; Pancreatic neuroendocrine tumor

Mesh:

Substances:

Year:  2016        PMID: 27688080     DOI: 10.1007/s12022-016-9455-2

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  32 in total

1.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

Review 2.  Digital microscopy: past, present, and future.

Authors:  Cyrus V Hedvat
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

3.  Endoscopic ultrasound-guided fine needle aspiration cytology of pancreatic neuroendocrine tumours: cytomorphological and immunocytochemical evaluation.

Authors:  F Chang; C Vu; A Chandra; J Meenan; A Herbert
Journal:  Cytopathology       Date:  2006-02       Impact factor: 2.073

4.  Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.

Authors:  B Weynand; I Borbath; V Bernard; C Sempoux; J-F Gigot; C Hubert; V Lannoy; P H Deprez; A Jouret-Mourin
Journal:  Cytopathology       Date:  2013-11-15       Impact factor: 2.073

5.  Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count.

Authors:  Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

6.  Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Authors:  Laura H Tang; Mithat Gonen; Cyrus Hedvat; Irvin M Modlin; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

7.  Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.

Authors:  Jessica M Farrell; Judy C Pang; Grace E Kim; Z Laura Tabatabai
Journal:  Cancer Cytopathol       Date:  2014-07-09       Impact factor: 5.284

8.  Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.

Authors:  Alberto Larghi; Gabriele Capurso; Antonella Carnuccio; Riccardo Ricci; Sergio Alfieri; Domenico Galasso; Francesca Lugli; Antonio Bianchi; Francesco Panzuto; Laura De Marinis; Massimo Falconi; Gianfranco Delle Fave; Giovanni Battista Doglietto; Guido Costamagna; Guido Rindi
Journal:  Gastrointest Endosc       Date:  2012-09       Impact factor: 9.427

9.  Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.

Authors:  Toshiyuki Hasegawa; Kenji Yamao; Susumu Hijioka; Vikram Bhatia; Nobumasa Mizuno; Kazuo Hara; Hiroshi Imaoka; Yasumasa Niwa; Masahiro Tajika; Shinya Kondo; Tutomu Tanaka; Yasuhiro Shimizu; Taira Kinoshita; Takuhiro Kohsaki; Isao Nishimori; Shinji Iwasaki; Toshiji Saibara; Waki Hosoda; Yasushi Yatabe
Journal:  Endoscopy       Date:  2013-11-11       Impact factor: 10.093

10.  Cytological diagnosis of endocrine tumors of the pancreas by endoscopic ultrasound-guided fine-needle aspiration biopsy.

Authors:  Mai Gu; Sophie Ghafari; Fritz Lin; Ibrahim Ramzy
Journal:  Diagn Cytopathol       Date:  2005-04       Impact factor: 1.582

View more
  5 in total

1.  Grading of pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspiration using Ki-67 index and 2017 World Health Organization criteria: An analysis of 32 cases.

Authors:  Sweety Kalantri; Pooja Bakshi; Kusum Verma
Journal:  Cytojournal       Date:  2020-09-18       Impact factor: 2.091

2.  Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNAC).

Authors:  Alessandro Gambella; Enrico Costantino Falco; Jasna Metovic; Francesca Maletta; Claudio De Angelis; Roberta Maragliano; Silvia Uccella; Donatella Pacchioni; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-06       Impact factor: 3.943

3.  Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.

Authors:  Wenzel M Hackeng; Folkert H M Morsink; Leon M G Moons; Christopher M Heaphy; G Johan A Offerhaus; Koen M A Dreijerink; Lodewijk A A Brosens
Journal:  Diagn Cytopathol       Date:  2019-12-17       Impact factor: 1.582

4.  Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.

Authors:  Alexander Appelstrand; Fredrik Bergstedt; Anna-Karin Elf; Henrik Fagman; Per Hedenström
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

5.  Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Authors:  Ferga C Gleeson; Jesse S Voss; Benjamin R Kipp; Sarah E Kerr; John S Van Arnam; John R Mills; Cherisse A Marcou; Amber R Schneider; Zheng Jin Tu; Michael R Henry; Michael J Levy
Journal:  Oncotarget       Date:  2017-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.